002365.SZ
Qianjiang Yongan Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 15.11
−8.92%Year over year
Reported trailing growth
- Revenue
- +4.3%
- EBITDA
- —
- EBIT
- -8.9%
- EPS
- +23.0%
- Free cash flow
- -4.4%
- Operating cash flow
- -16.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -18.8%
- EBITDA
- -22.7%
- EBIT
- -58.8%
- Net income
- -45.7%
- EPS
- -45.4%
- Free cash flow
- -31.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026